secwatch.observer — SEC 8-K summary
======================================

Issuer:     NIKA PHARMACEUTICALS, INC (NIKA)
CIK:        0001145604
Form:       8-K
Filed at:   2022-08-22T23:59:59+00:00
Accession:  0001826466-22-000105
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Centennial Growth Equities changes name to Nika Pharmaceuticals, authorizes 2.7B shares
--------------------------------------------------------------------------------

- Shareholders approved name change from Centennial Growth Equities to Nika Pharmaceuticals.
- Authorized common stock increased from 90M to 2.7B shares at $0.001 par value.
- Subsequent amendment reduced par value to $0.0001 per share for common and preferred.
- Bylaws amended to permit electronic notice and online shareholder meetings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145604/000182646622000105/0001826466-22-000105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145604/000182646622000105/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001826466-22-000105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer